The use of a H3R inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (PD)

摘要

The invention relates to the use of Compound (I), as defined herein, or pharmaceutically acceptable salt thereof, in the treatment of excessive daytime sleepiness associated with Parkinson's disease.